Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin DiFrancesco

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
AIDS (London, England)|December 31, 2008
A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patientsLisa M Demeter, Hongyu Jiang, A Lisa Mukherjee, et al.
Current Vascular Pharmacology|January 7, 2016
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related DisordersCindy Bednasz, Amneris E Luque, Barry S Zingman, et al.
Clinical Drug Investigation|January 15, 2013
Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected WomenCharles E Frost, John Adams, Mark Shelton, et al.
Therapeutic Drug Monitoring|September 28, 2007
Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoringJudianne Slish, Qing Ma, Barry S Zingman, et al.
Journal of Clinical Pharmacology|January 7, 2011
Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and Caucasian renal transplant recipientsKathleen M Tornatore, Patcharaporn Sudchada, Kiran Dole, et al.
Pharmacogenomics|February 28, 2007
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIVQing Ma, Daniel Brazeau, Barry S Zingman, et al.
Journal of Clinical Pharmacology|February 20, 2004
The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadoneMark J Shelton, Denise Cloen, Robin DiFrancesco, et al.
African Journal of Laboratory Medicine|August 16, 2021
Cross-validation of a high-performance liquid chromatography nevirapine plasma assay in a resource-limited setting in ZimbabweFaithful Makita-Chingombe, Anthony T Podany, Timothy Mykris, et al.
The American Journal on Addictions|December 7, 2007
Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavirNiamh Higgins, Barry S Zingman, Judianne Slish, et al.
Journal of Public Health in Africa|April 8, 2020
Mentored postdoctoral training in Zimbabwe: A report on a successful collaborative effortDanai T Zhou, Charles C Maponga, Munyaradzi Madhombiro, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
AIDS (London, England)|December 31, 2008
A randomized trial of therapeutic drug monitoring of protease inhibitors in antiretroviral-experienced, HIV-1-infected patientsLisa M Demeter, Hongyu Jiang, A Lisa Mukherjee, et al.
Current Vascular Pharmacology|January 7, 2016
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related DisordersCindy Bednasz, Amneris E Luque, Barry S Zingman, et al.
Clinical Drug Investigation|January 15, 2013
Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected WomenCharles E Frost, John Adams, Mark Shelton, et al.
Therapeutic Drug Monitoring|September 28, 2007
Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoringJudianne Slish, Qing Ma, Barry S Zingman, et al.
Journal of Clinical Pharmacology|January 7, 2011
Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and Caucasian renal transplant recipientsKathleen M Tornatore, Patcharaporn Sudchada, Kiran Dole, et al.
Pharmacogenomics|February 28, 2007
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIVQing Ma, Daniel Brazeau, Barry S Zingman, et al.
Journal of Clinical Pharmacology|February 20, 2004
The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadoneMark J Shelton, Denise Cloen, Robin DiFrancesco, et al.
African Journal of Laboratory Medicine|August 16, 2021
Cross-validation of a high-performance liquid chromatography nevirapine plasma assay in a resource-limited setting in ZimbabweFaithful Makita-Chingombe, Anthony T Podany, Timothy Mykris, et al.
The American Journal on Addictions|December 7, 2007
Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavirNiamh Higgins, Barry S Zingman, Judianne Slish, et al.
Journal of Public Health in Africa|April 8, 2020
Mentored postdoctoral training in Zimbabwe: A report on a successful collaborative effortDanai T Zhou, Charles C Maponga, Munyaradzi Madhombiro, et al.
Pageof 6